Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma

Antibodies are considered highly specific therapeutic agents in cancer medicines, and numerous formats have been developed. Among them, bispecific antibodies (BsAbs) have gained a lot of attention as a next-generation strategy for cancer therapy. However, poor tumor penetration is a major challenge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamara, Saidu, Guo, Yanru, Wen, He, Liu, Ying, Liu, Lei, Zheng, Maolin, Zhang, Jing, Zhou, Luqi, Chen, Jun, Zhu, Shanli, Zhang, Lifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299379/
https://www.ncbi.nlm.nih.gov/pubmed/37373272
http://dx.doi.org/10.3390/ijms241210126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299379/
https://www.ncbi.nlm.nih.gov/pubmed/37373272
http://dx.doi.org/10.3390/ijms241210126

Ejemplares similares